NLS Pharmaceutics AG logo

NLSPNLS Pharmaceutics AG

NLSP Stock Price, Valuation & Chart | NLS Pharmaceutics AG

Compare

NLSP Historical price chart

NLSP Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization919.60K
PE Ratio-0.17
EPS-17.4
Trading Volume113.99K
Today's High/Low3.51/2.91
Dividend Yield0.00
52 Week High/Low43.4/0.76
Shares Outstanding316.01K
NLSP Financial Statement
NLSP Analyst ratings
NLSP Analysis & performance metrics

NLSP Company profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.…

NLSP Management team

Management
Alexander Zwyer M.B.A.CEO
Co-Founder, Chief Executive Officer & Director
Eric Konofal M.D., Ph.D.
Co-Founder & Chief Scientific Officer
Total 2 executives

NLSP Frequently asked questions

What is NLS Pharmaceutics AG (NLSP) Stock Price?

Current stock price of NLS Pharmaceutics AG (NLSP) stock is $2.910. The stock price is -12.61% lower in the session. The intraday range can be seen from this page. Volume of NLS Pharmaceutics AG (NLSP) stock is 113.99K.

Last updated at 12 Dec 2025, 02:30 pm.

Why is the NLS Pharmaceutics AG (NLSP) stock price going up or down today?

The stock price of NLS Pharmaceutics AG (NLSP) can change with earnings, company news, and overall market sentiment. NLS Pharmaceutics AG operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NLS Pharmaceutics AG stock expensive at its current price?

Whether NLS Pharmaceutics AG looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NLSP on this page is -0.17. EPS on this page is -17.40. Compare those figures with peers and growth expectations before deciding if the current NLS Pharmaceutics AG price is justified.

How has the stock price of NLS Pharmaceutics AG (NLSP) performed historically?

Historical performance for NLS Pharmaceutics AG (NLSP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NLSP reacted to past earnings and market events.

Should I buy NLS Pharmaceutics AG (NLSP) stock, at this price?

Buying NLS Pharmaceutics AG (NLSP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.